price
MX
NASDAQ · MXCT
MaxCyte, Inc.
Healthcare · Medical - Devices
$1.46
Down-$0.07 (-4.79%)
Updated Nov 5, 2026, 1:20 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 170.68M
- P/E ratio
- -3.73
- Dividend yield
- 0.00%
- 52-week range
- $0.64 – $1.81
- Volume
- 1.03M
- Avg. volume
- 961.6K
Price performance · MXCT
MXCT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
MXCT closed at $1.46 after 20 trading sessions, up 40.38% for the selected period.
- Last close
- $1.46
- Period change
- +40.38%
- Period low
- $0.96
- Period high
- $1.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $1.51 | $1.51 | $1.365 | $1.46 | 1.03M |
| Nov 2, 2026 | $1.59 | $1.705 | $1.43 | $1.45 | 1.28M |
| Oct 30, 2026 | $1.71 | $1.72 | $1.505 | $1.59 | 963.82K |
| Oct 29, 2026 | $1.73 | $1.76 | $1.6229 | $1.73 | 1.14M |
| Oct 28, 2026 | $1.50 | $1.73 | $1.50 | $1.71 | 1.71M |
| Oct 27, 2026 | $1.51 | $1.64 | $1.51 | $1.54 | 1.58M |
| Oct 26, 2026 | $1.39 | $1.53 | $1.3649 | $1.51 | 1.13M |
| Oct 23, 2026 | $1.43 | $1.43 | $1.35 | $1.40 | 757.46K |
| Oct 22, 2026 | $1.44 | $1.51 | $1.43 | $1.43 | 1.02M |
| Oct 21, 2026 | $1.42 | $1.53 | $1.405 | $1.47 | 1.42M |
| Oct 20, 2026 | $1.29 | $1.4567 | $1.29 | $1.43 | 1.39M |
| Oct 19, 2026 | $1.30 | $1.31 | $1.27 | $1.30 | 986.46K |
| Oct 16, 2026 | $1.32 | $1.32 | $1.28 | $1.30 | 1.01M |
| Oct 15, 2026 | $1.27 | $1.31 | $1.255 | $1.30 | 3.79M |
| Oct 14, 2026 | $1.225 | $1.33 | $1.195 | $1.25 | 12.67M |
| Oct 13, 2026 | $0.9813 | $1.01 | $0.9361 | $0.9643 | 327.91K |
| Oct 12, 2026 | $1.01 | $1.01 | $0.9722 | $0.995 | 150.12K |
| Oct 9, 2026 | $1.02 | $1.03 | $0.99 | $1.01 | 240.01K |
| Oct 8, 2026 | $1.04 | $1.04 | $0.9636 | $1.02 | 476.76K |
| Oct 7, 2026 | $1.07 | $1.08 | $1.04 | $1.04 | 311.95K |
Latest MXCT news
The latest Smart Investors Daily articles mentioning MXCT.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…